![Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients | Scientific Reports Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-55515-x/MediaObjects/41598_2019_55515_Fig1_HTML.png)
Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients | Scientific Reports
![Space-time analysis of ovarian cancer mortality rates by age groups in spanish provinces (1989–2015) | BMC Public Health | Full Text Space-time analysis of ovarian cancer mortality rates by age groups in spanish provinces (1989–2015) | BMC Public Health | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12889-020-09267-3/MediaObjects/12889_2020_9267_Fig1_HTML.png)
Space-time analysis of ovarian cancer mortality rates by age groups in spanish provinces (1989–2015) | BMC Public Health | Full Text
![Ovarian, Fallopian Tube and Primary Peritoneal Cancer (including Borderline) (Chapter 10) - Gynaecological Oncology for the MRCOG Ovarian, Fallopian Tube and Primary Peritoneal Cancer (including Borderline) (Chapter 10) - Gynaecological Oncology for the MRCOG](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20180510054848968-0632:9781316986844:63871fig10_1.png?pub-status=live)
Ovarian, Fallopian Tube and Primary Peritoneal Cancer (including Borderline) (Chapter 10) - Gynaecological Oncology for the MRCOG
![JCM | Free Full-Text | Epidemiology and Mortality of Ovarian Cancer in Taiwan: A Population-Based Study JCM | Free Full-Text | Epidemiology and Mortality of Ovarian Cancer in Taiwan: A Population-Based Study](https://www.mdpi.com/jcm/jcm-11-05627/article_deploy/html/images/jcm-11-05627-g001a.png)
JCM | Free Full-Text | Epidemiology and Mortality of Ovarian Cancer in Taiwan: A Population-Based Study
![Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries - Sung - 2021 - CA: A Cancer Journal for Clinicians - Wiley Online Library Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries - Sung - 2021 - CA: A Cancer Journal for Clinicians - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/eab110f9-a9b5-4d12-ab6e-e545f95ef52e/caac21660-fig-0004-m.jpg)
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries - Sung - 2021 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Distribution of ovarian cancer patients according to the age at diagnosis. | Download Scientific Diagram
Descriptive Epidemiology of breast and gynecological cancers among patients attending Saint Paul's Hospital Millennium Medical College, Ethiopia | PLOS ONE
![CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice](https://bjgp.org/content/bjgp/71/707/e465/F1.large.jpg?width=800&height=600&carousel=1)
CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice
![Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis | BMC Cancer | Full Text Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-6139-6/MediaObjects/12885_2019_6139_Fig1_HTML.png)
Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis | BMC Cancer | Full Text
![Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial - The Lancet Oncology Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/b83343ff-8cfa-437b-996b-f0d1f61b1841/gr1.jpg)